SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-18-233032
Filing Date
2018-07-31
Accepted
2018-07-31 15:10:58
Documents
3
Group Members
CHARLES E. GALECHARLES E. GALE FIDELITY ROLLOVER IRACHARLES HENRY ROSE 2001 TRUSTEVELYN P. ROSEEVELYN P. ROSE FIDELITY SEP IRAEVELYN POTTER ROSE SURVIVOR'S TRUSTJOHN WILLIAM ROSE 2002 TRUSTMONTROSE INVESTMENTS GP, LLCMONTROSE INVESTMENTS I, L.P.PUFFIN GP,

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d568542dsc13da.htm SC 13D/A 234888
2 EX-7.4 d568542dex74.htm EX-7.4 16407
3 EX-7.5 d568542dex75.htm EX-7.5 16873
  Complete submission text file 0001193125-18-233032.txt   269868
Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address
ROSE WILLIAM (Filed by) CIK: 0001193284 (see all company filings)

Type: SC 13D/A

Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89517 | Film No.: 18980896
SIC: 2834 Pharmaceutical Preparations